Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 7,157,470

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,157,470
Title:Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
Abstract: The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula I: ##STR00001## or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
Inventor(s): Smallheer; Joanne M. (Yardley, PA), Pinto; Donald J. (Kennett Square, PA), Wang; Shuaige (West Chester, PA), Qiao; Jennifer X. (Princeton, NJ), Han; Wei (Yardley, PA), Hu; Zilun (Thornton, PA)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:10/429,461
Patent Claims:see list of patent claims

Details for Patent 7,157,470

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22   Start Trial Bristol-Myers Squibb Company (Princeton, NJ) 2022-05-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 7,157,470

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.